HomeEditorials and Commentaries

Editorials and Commentaries

It’s a Good News-Bad News Kind of Thing…

Editorial Team-November 6, 2020

Doctor discussing treatment options with a patient.

Patient-First Specialty Rx Solutions Expedite Trials, Enhance Compliance and Improve Experience

Precision Technology Transforms the Way Leading Hospitals Diagnose and Treat Prostate Cancer

Scientist working in the biosafety cabinet

Why Doctors Don’t Trust Cannabis

Featured Image: Pipette with Cannabis oil. Photo Credit: © 2018 - 2020 Fotolia/Adobe

Providing the Legitimacy of Cannabinoids for the Treatment of Cancer

Want to Improve Patient Relationships? Let Them Express Their Preferences

Jeff Jarvis-March 5, 2020

Physician consulting with a patients in hospital exam room.

The Emotional and Psychological Struggle of Being a Doctor

Shannon Sovndal, MD-February 21, 2020

The Nuts & Bolts of High Intensity Focal Ultrasound

John Russell Valvo, MD-January 10, 2020

12 3...6 Page 1 of 6

LATEST NEWS

Theranostics Technology: A New Approach to Cancer Diagnosis and Treatment

Jill S. Helmke, D.Ph., N.Ph.-December 29, 2020

Scalp Cooling in ESMO’S Clinical Practice Guidelines to help Prevent Chemotherapy-induced Alopecia

Peter Hofland, Ph.D-December 23, 2020

Study Confirms Safety of Head and Neck Cancer Surgery During the COVID-19 pandemic

Peter Hofland, Ph.D-December 21, 2020

Analysis Shows Incidence of Advanced Stage Esophageal Adenocarcinoma Increasing in Younger Adults

Peter Hofland, Ph.D-December 16, 2020

First-in-class Noninvasive Therapy for Glioblastoma Enters Phase 0 Trial at Ivy Brain Tumor Center

Peter Hofland, Ph.D-December 14, 2020

Press Releases | Cancer

Robert Embree and Jason Allchin Team Up to Start EmeritusDXJanuary 20, 2021
Highly Accomplished Leaders within the Healthcare Industry Start Diagnostic Company in Pursuit of Uncompromising Patient Care(PRWeb January 20, 2021)Read the full story at https://www.prweb.com/releases/robert_embree_and_jason_allchin_team_up_to_start_emeritusdx/prweb17669232.htm
MyID Launches Partnership with Merck & Co, Inc. for KEYTRUDA®...January 20, 2021
Company's Mobile App Will Provide Critical Information to Providers(PRWeb January 20, 2021)Read the full story at https://www.prweb.com/releases/myid_launches_partnership_with_merck_co_inc_for_keytruda_patients/prweb17671554.htm
CORE Magazine Announces 100 Most Influential Blacks TodayJanuary 19, 2021
Special Issue Magazine of Inspirational Americans to debut February 1, 2021.(PRWeb January 19, 2021)Read the full story at https://www.prweb.com/releases/core_magazine_announces_100_most_influential_blacks_today/prweb17669341.htm

Editorials and Commentaries

It’s a Good News-Bad News Kind of Thing…

Patient-First Specialty Rx Solutions Expedite Trials, Enhance Compliance and Improve Experience

Precision Technology Transforms the Way Leading Hospitals Diagnose and Treat Prostate Cancer

Why Doctors Don’t Trust Cannabis

Providing the Legitimacy of Cannabinoids for the Treatment of Cancer

The Value of Biosimilars in the Pandemic Era

Re-Engineering Molecules to Drive Innovation in Cancer Immunotherapy

COVID19 and Bladder Cancer – Adapting to a New Reality

The Road to Recovery Must Include Communities of Color

Coronavirus Prevention for Cancer Patients and Their Caregivers

Managing the Viral Scourge – How to Find Hope and Face...

Three Necessary Pillars to Revolutionize Clinical Trial Design

Want to Improve Patient Relationships? Let Them Express Their Preferences

The Emotional and Psychological Struggle of Being a Doctor

The Nuts & Bolts of High Intensity Focal Ultrasound

LATEST NEWS

Theranostics Technology: A New Approach to Cancer Diagnosis and Treatment

Scalp Cooling in ESMO’S Clinical Practice Guidelines to help Prevent Chemotherapy-induced Alopecia

Study Confirms Safety of Head and Neck Cancer Surgery During the COVID-19 pandemic

Analysis Shows Incidence of Advanced Stage Esophageal Adenocarcinoma Increasing in Younger Adults

First-in-class Noninvasive Therapy for Glioblastoma Enters Phase 0 Trial at Ivy Brain Tumor Center

Theranostics Technology: A New Approach to Cancer Diagnosis and Treatment

Scalp Cooling in ESMO’S Clinical Practice Guidelines to help Prevent Chemotherapy-induced Alopecia

Study Confirms Safety of Head and Neck Cancer Surgery During the COVID-19 pandemic

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...